CVS HEALTH Corp.
- CVS · NYSE
- Retail-Drug Stores and Proprietary Stores
- Woonsocket, RI
- 300,000 employees
- CIK 0000064803
Updated from SEC filings through
Top things to know
Executives
- J. David Joyner President, CEO and Chair 4, 2026-04-02
- Brian Newman EVP, Chief Financial Officer 4, 2026-06-01
- Brian O. Newman Executive Vice President and Chief Financial Officer 10-K, 2026-02-10
- James David Clark SVP, Cont & Chief Acct Officer 4, 2026-06-29
- Amy Compton-Phillips EVP, Chief Medical Officer 4, 2026-06-01
- Tilak Mandadi EVP, Chief Exp & Tech Officer 4, 2026-05-11
CVS HEALTH Corp is a U.S. public company in retail-drug stores and proprietary stores (SIC 5912), headquartered in Woonsocket, RI. It trades as CVS on NYSE. Revenue was $402B in the fiscal year ending December 31, 2025, +7.8% from the year before. It reported about 300,000 employees. J. David Joyner is President, CEO and Chair.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $402B 10-K, 2026-02-10 | $373B 10-K, 2026-02-10 | $358B 10-K, 2026-02-10 | $322B 10-K, 2025-02-12 | $292B 10-K, 2024-02-07 |
| Operating income | $4.7B 10-K, 2026-02-10 | $8.5B 10-K, 2026-02-10 | $13.7B 10-K, 2026-02-10 | $8.0B 10-K, 2025-02-12 | $13.3B 10-K, 2024-02-07 |
| SG&A | Not on file | Not on file | Not on file | Not on file | Not on file |
| Net income | $1.8B 10-K, 2026-02-10 | $4.6B 10-K, 2026-02-10 | $8.3B 10-K, 2026-02-10 | $4.3B 10-K, 2025-02-12 | $8.0B 10-K, 2024-02-07 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| J. David Joyner Chairman and CEO, CVS Health | President, CEO and Chair | 4, 2026-04-02 |
| Brian Newman | EVP, Chief Financial Officer | 4, 2026-06-01 |
| Thomas F. Cowhey | Named in proxy bio: Former Executive Vice President and Chief Financial Officer | DEF 14A, 2026-04-03 |
| Brian O. Newman | Executive Vice President and Chief Financial Officer | 10-K, 2026-02-10 |
| James David Clark | SVP, Cont & Chief Acct Officer | 4, 2026-06-29 |
| Amy Compton-Phillips Physician, Executive, Board Member, Keynote Speaker, Author, and visionary leader driven to make great health and compassionate care available for all. | EVP, Chief Medical Officer | 4, 2026-06-01 |
| Tilak Mandadi EVP - Ventures and Chief Experience and Technology Officer, CVS Health | EVP, Chief Exp & Tech Officer | 4, 2026-05-11 |
| Heidi B. Capozzi EVP and Chief People Officer at CVS Health | EVP and Chief People Officer | 4, 2026-04-02 |
| Prem S. Shah | EVP and Group President | 4, 2026-04-02 |
| Steven H. Nelson | EVP and President, Aetna | 4, 2026-04-02 |
| Amy Compton-Philips | Executive Vice President and Chief Medical Officer | 10-K, 2026-02-10 |
| James D. Clark | Senior Vice President, Controller and Chief Accounting Officer | 10-K, 2026-02-10 |
| David Brown | Board member (per proxy) bio: Chair of the Management Planning and Development Committee | DEF 14A, 2026-04-03 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 4, 2026-04-02 |
| Teresa Heitsenrether | Board | 8-K, 2026-08-17 |
| John E. Gallina | Board member (per proxy) bio: Board | DEF 14A, 2026-04-03 |
What CVS HEALTH Corp does
CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 1.28 billion (as of October 28, 2026) | 10-Q, November 4, 2026 |
|---|---|---|
| Public float | $86.4B (as of June 30, 2025) | 10-K, February 10, 2026 |
| Reportable segments | 4 (period ending September 30, 2026) | 10-Q, November 4, 2026 |
| Latest proxy statement | Meeting May 14, 2026 (filed April 3, 2026) | DEF 14A, April 3, 2026 |
| Auditor | Ernst & Young LLP (Boston, Massachusetts) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| November 6, 2026 | Prem S. Shah EVP and Group President | Buy | 23,855 | $2.0M | Form 4, November 6, 2026 |
| May 21, 2026 | Larry Robbins Director | Sale | 3,372,000 | $317M | Form 4, May 21, 2026 |
| May 8, 2026 | Tilak Mandadi EVP, Chief Exp & Tech Officer | Sale | 69,551 | $6.2M | Form 4, May 11, 2026 |
| August 20, 2025 | Anne A. Finucane Director | Sale | 7,500 | $533K | Form 4, August 29, 2025 |
| January 23, 2025 | Steven H. Nelson EVP and President, Aetna | Buy | 24 | $1K | Form 4, January 27, 2026 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-17
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-05-18
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-19
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-02-10
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-12-09
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-11-20
- Item 8.01 Other events
Frequently asked questions about CVS HEALTH Corp
- What does CVS HEALTH Corp do?
- In its own words, from Item 1 of its 10-K: "CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions."
- What is CVS HEALTH Corp's revenue?
- $402B for the fiscal year ending December 31, 2025, from its 10-K filed February 10, 2026.
- Is CVS HEALTH Corp profitable?
- CVS HEALTH Corp reported net income of $1.8B for the fiscal year ending December 31, 2025.
- How many employees does CVS HEALTH Corp have?
- About 300,000 as of February 10, 2026, as stated in its annual report.
- Who is the CEO of CVS HEALTH Corp?
- J. David Joyner, President, CEO and Chair, as named in a 4 filed April 2, 2026.
- Who is the CFO of CVS HEALTH Corp?
- Brian Newman, EVP, Chief Financial Officer, as named in a 4 filed June 1, 2026.
- Where is CVS HEALTH Corp headquartered?
- Woonsocket, RI.
- What is CVS HEALTH Corp's stock ticker?
- CVS on NYSE.
- What industry is CVS HEALTH Corp in?
- Retail-Drug Stores and Proprietary Stores, SIC code 5912.
- What is CVS HEALTH Corp's website?
- cvshealth.com. Investor relations: https://investors.cvshealth.com/?cid=site-CVSHealth:SuperNav:investors:na.
- When does CVS HEALTH Corp report earnings next?
- February 3, 2027. Source: estimate_8k_pattern.
- Is CVS HEALTH Corp a public company?
- Yes. CVS HEALTH Corp files with the SEC under CIK 0000064803 and trades as CVS.
- Who audits CVS HEALTH Corp?
- Ernst & Young LLP, Boston, Massachusetts, as named in its latest annual report (10-K).
- How many shares of CVS HEALTH Corp are outstanding?
- 1.28 billion shares as of October 28, 2026, from its 10-Q filed November 4, 2026.
- What is CVS HEALTH Corp's public float?
- $86.4B as of June 30, 2025, as reported on the cover of its 10-K filed February 10, 2026.
- How many business segments does CVS HEALTH Corp report?
- 4 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 4, 2026.
- When is CVS HEALTH Corp's annual shareholder meeting?
- May 14, 2026, per its proxy statement (DEF 14A) filed April 3, 2026.
- Have CVS HEALTH Corp insiders traded stock recently?
- Since January 23, 2025, officers and directors reported 3 open-market sales worth about $324M and 2 purchases worth about $2.0M on Forms 4 and 5. The most recent: Prem S. Shah (EVP and Group President) bought 23,855 shares on November 6, 2026.